1. Home
  2. BVS vs CYD Comparison

BVS vs CYD Comparison

Compare BVS & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • CYD
  • Stock Information
  • Founded
  • BVS 2011
  • CYD 1951
  • Country
  • BVS United States
  • CYD Singapore
  • Employees
  • BVS N/A
  • CYD N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CYD Industrial Machinery/Components
  • Sector
  • BVS Health Care
  • CYD Industrials
  • Exchange
  • BVS Nasdaq
  • CYD Nasdaq
  • Market Cap
  • BVS 656.9M
  • CYD 609.7M
  • IPO Year
  • BVS 2021
  • CYD 1994
  • Fundamental
  • Price
  • BVS $7.82
  • CYD $14.30
  • Analyst Decision
  • BVS Strong Buy
  • CYD
  • Analyst Count
  • BVS 4
  • CYD 0
  • Target Price
  • BVS $15.00
  • CYD N/A
  • AVG Volume (30 Days)
  • BVS 339.2K
  • CYD 297.9K
  • Earning Date
  • BVS 05-06-2025
  • CYD 02-25-2025
  • Dividend Yield
  • BVS N/A
  • CYD 2.66%
  • EPS Growth
  • BVS N/A
  • CYD 17.49
  • EPS
  • BVS N/A
  • CYD 1.12
  • Revenue
  • BVS $573,280,000.00
  • CYD $2,621,360,849.00
  • Revenue This Year
  • BVS N/A
  • CYD $6.43
  • Revenue Next Year
  • BVS $6.09
  • CYD $11.20
  • P/E Ratio
  • BVS N/A
  • CYD $12.71
  • Revenue Growth
  • BVS 11.89
  • CYD 6.03
  • 52 Week Low
  • BVS $3.90
  • CYD $7.95
  • 52 Week High
  • BVS $14.38
  • CYD $26.10
  • Technical
  • Relative Strength Index (RSI)
  • BVS 37.22
  • CYD 41.54
  • Support Level
  • BVS $7.56
  • CYD $13.96
  • Resistance Level
  • BVS $8.66
  • CYD $17.00
  • Average True Range (ATR)
  • BVS 0.61
  • CYD 1.34
  • MACD
  • BVS -0.05
  • CYD -0.14
  • Stochastic Oscillator
  • BVS 28.40
  • CYD 29.29

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: